Optimise Your Workflow and Resources: Make the right decisions with fast PCR admission screening¹ in <1 hour*

Fast and accurate PCR with Cepheid’s GeneXpert® system enables on-demand patient status identification, for improved patient flow, experience and outcomes.²

Explore fast, on-demand testing with your complete surgical bundle:


Sample In, Answer Out: 3 simple steps

Easy-to-use cartridge technology provides standardised results in the lab or decentralised settings, 24/7. 


Patient Pathway Impact: Right patient, right bed, right time

Cepheid’s on-demand testing solutions provide high-quality answers, anywhere and anytime your patients need care.


CE-IVD In Vitro Diagnostic Medical Device. May not be available in all countries.
^Refer to products package insert for intended use and product claims
* Turnaround times vary by test. See individual Product Inserts for specific turnaround times. For positive COVID-19 reporting with Early Assay Termination (EAT). Reporting negatives in 45 minutes.

  1. Refer to products package insert for intended use and product claims. 
  2. Bouza E, et al. Colonization of the nasal airways by Staphylococcus aureus on admission to a major heart surgery operating room: A real-world experience. Enfermedades Infecciosas y Microbiología Clínica. 2020 Dec;38(10):466-470.

Discover how you can implement a GeneXpert® System in your institution

*required fields
Cepheid respects your privacy, and values the relationship with our customers, partners, and associates. Your personal data may be processed by Cepheid, its affiliates, representatives and other Danaher companies for business and marketing purposes. You can review Cepheid Privacy Policy online for additional information on your rights and how we use and share personal data we collect on our websites and other channels. Your consent to receiving Cepheid news can be withdrawn at any time. Building a relationship of trust is important to us and we will happily help with any questions on your personal data processing addressed to Privacy.officer@cepheid.com

About Cepheid

Cepheid is a leading molecular diagnostics company that is an operating company within Danaher Corporation’s (NYSE: DHR) Diagnostics platform.
Cepheid is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests.
By automating highly complex and time-consuming manual procedures, the company’s solutions deliver a better way for institutions of any size to perform sophisticated molecular diagnostic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer.

For more information, visit www.cepheid.com/en.

Cepheid Logo

Vira Solelh
81470 Maurens-Scopont France
+33.563.82.53.00 | www.Cepheid.com

© 2022 Cepheid. All Rights Reserved. Privacy Policy | Cookies Settings